Laser Assisted ICSI; Has it Role Whatsoever?

September 18, 2022 updated by: Royal Fertility Center, Egypt

Laser Assisted ICSI; Has it Role Whatsoever? Does it Affect the ICSI Outcome Positively?1

laser-assisted ICSI (LA-ICSI) was described to be a new method combining a less invasive ICSI technique with assisted hatching.This procedure is usually used for MII oocytes possessing oolemma breakage difficulties, but why not using it for even normal Oocytes?!. Especially because data indicated that in addition to an improved oocyte survival, this new approach increases the hatching rate in vitro. But since it is still debatable that such a small opening might impair the hatching process, so modified zona thinning technique was proposed for more embryo safety.

Study Overview

Status

Suspended

Intervention / Treatment

Detailed Description

This study aims to compare the LA- ICSI by drilling a micro hole (LAD-ICSI) and modified LA-ICSI by zona pellucida thinning (LAT-ICSI) with conventional ICSI in order to effectively assess whether this approach can be applied routinely to improve ICSI outcome.

One arm study divided into three interventions; Conventional ICSI (control group) was compared with LAD-ICSI (Study group 1) and LAT- ICSI (study group 2) in sibling oocytes.

The rates of maturation, fertilization, Devision, Blastulation and good quality blastulation rates were assessed in the three groups

Cases were randomly selected for embryo transfer from the three groups,Then chemical pregnancy and clinical pregnancy rates were compared between the three groups.

Study Type

Interventional

Enrollment (Anticipated)

120

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Daqahlia
      • Mansoura, Daqahlia, Egypt, 12111
        • Royal Fertility Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 37 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Patients aged from 20 years old to 37 years old
  • good res-ponders
  • gives more than 15 oocytes
  • endometrial thickness more than 9 mm

Exclusion Criteria:

  • poor res-ponders
  • severe oligoasthinozoospermia of male partners
  • testicular samples
  • Poor quality oocytes

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: control group
Conventional ICSI procedure was done for first portion of sibling oocytes
Experimental: Study group 1
Laser assisted drilling ICSI procedure was done for second portion of sibling oocytes
using OCTICS laser device to do small opening or zona thinning to improve ICSI outcome
Experimental: Study group 2
Laser assisted thinning ICSI procedure was done for Third portion of sibling oocytes
using OCTICS laser device to do small opening or zona thinning to improve ICSI outcome

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Clinical pregnancy rate
Time Frame: three-four weeks after embryo transfer
confirmed by sac observation using ultrasound
three-four weeks after embryo transfer

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Blastulation rate
Time Frame: 5 days later after ICSI procedure
number of blastocysts that are grown from devided embryos
5 days later after ICSI procedure
Hatching rate
Time Frame: 5 days later after ICSI procedure
number of blastocysts that hatch out of zona
5 days later after ICSI procedure

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2020

Primary Completion (Anticipated)

December 1, 2023

Study Completion (Anticipated)

January 1, 2024

Study Registration Dates

First Submitted

June 28, 2020

First Submitted That Met QC Criteria

June 28, 2020

First Posted (Actual)

July 2, 2020

Study Record Updates

Last Update Posted (Actual)

September 21, 2022

Last Update Submitted That Met QC Criteria

September 18, 2022

Last Verified

September 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • RoyalFertility 001

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Laser Assisted ICSI

Subscribe